Andrew has 20 years of experience advising executive teams and boards of directors on long-term corporate positioning, media and investor relations programs and high-stakes situations including cyberattacks, initial public offerings, litigation, mergers & acquisitions, proxy contests, and senior management changes.

Engagements include:

• Bioverativ on its sale to Sanofi
• Insmed on its announcement of Phase 3 data results for its lead product candidate
• Providence Equity Partners on its long-term corporate positioning and transaction announcements

Andrew joined SVC in 1998 from Gavin Anderson & Company. From 2006 to 2009, he worked in the San Francisco office.

Andrew received a B.A. in English from Connecticut College.

Get In Touch

acole@sardverb.com vCard